Show simple item record

dc.contributor.authorSerra, V.
dc.contributor.authorEichhorn, Pieter
dc.contributor.authorGarcía-García, C.
dc.contributor.authorIbrahim, Y.
dc.contributor.authorPrudkin, L.
dc.contributor.authorSánchez, G.
dc.contributor.authorRodríguez, O.
dc.contributor.authorAntón, P.
dc.contributor.authorParra, J.
dc.contributor.authorMarlow, S.
dc.contributor.authorScaltriti, M.
dc.contributor.authorPérez-Garcia, J.
dc.contributor.authorPrat, A.
dc.contributor.authorArribas, J.
dc.contributor.authorHahn, W.
dc.contributor.authorKim, S.
dc.contributor.authorBaselga, J.
dc.date.accessioned2018-12-13T09:09:13Z
dc.date.available2018-12-13T09:09:13Z
dc.date.created2018-12-12T02:47:09Z
dc.date.issued2014
dc.identifier.citationSerra, V. and Eichhorn, P. and García-García, C. and Ibrahim, Y. and Prudkin, L. and Sánchez, G. and Rodríguez, O. et al. 2014. Erratum: RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer (Journal of Clinical Investigation (2013) 123:6 (2551-2563) DOI:10.1172/JCI66343). Journal of Clinical Investigation. 124 (3).
dc.identifier.urihttp://hdl.handle.net/20.500.11937/71201
dc.identifier.doi10.1172/JCI75534
dc.publisherAmerican Society for Clinical Investigation
dc.titleErratum: RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer (Journal of Clinical Investigation (2013) 123:6 (2551-2563) DOI:10.1172/JCI66343)
dc.typeJournal Article
dcterms.source.volume124
dcterms.source.number3
dcterms.source.issn0021-9738
dcterms.source.titleJournal of Clinical Investigation
curtin.departmentSchool of Pharmacy and Biomedical Sciences
curtin.accessStatusFulltext not available


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record